Skip to main content
OpenTrials

Clinical trial condition

Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer

Explore clinical trials studying Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer trial results

Recruiting

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

NCT02926690

Conditions
Breast Diseases, Breast Neoplasms, Disease Attributes, +9 more
Locations
  • Norwalk Hospital Norwalk, Connecticut, United States
  • Emory University, Winship Cancer Institute Atlanta, Georgia, United States
  • Kapi'olani Medical Center for Women & Children Honolulu, Hawaii, United States
  • Dartmouth Cancer Center/Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
View Trial Details

Related conditions